Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Philippe Renaudier is active.

Publication


Featured researches published by Philippe Renaudier.


PLOS ONE | 2010

The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa

Annie J. Sasco; Antoine Jaquet; Emilie Boidin; Didier K. Ekouevi; Fabian Thouillot; Thomas LeMabec; Marie-Anna Forstin; Philippe Renaudier; Paul Ndom; Denis Malvy; François Dabis

Background With the lengthening of life expectancy among HIV-positive subjects related to the use of highly active antiretroviral treatments, an increased risk of cancer has been described in industrialized countries. The question is to determine what occurs now and will happen in the future in the low income countries and particularly in sub-Saharan Africa where more than two-thirds of all HIV-positive people live in the world. The objective of our paper is to review the link between HIV and cancer in sub-Saharan Africa, putting it in perspective with what is already known in Western countries. Methods and Findings Studies for this review were identified from several bibliographical databases including Pubmed, Scopus, Cochrane, Pascal, Web of Science and using keywords “HIV, neoplasia, epidemiology and Africa” and related MesH terms. A clear association was found between HIV infection and AIDS-classifying cancers. In case-referent studies, odds ratios (OR) were ranging from 21.9 (95% Confidence Interval (CI) 12.5–38.6) to 47.1 (31.9–69.8) for Kaposi sarcoma and from 5.0 (2.7–9.5) to 12.6 (2.2–54.4) for non Hodgkin lymphoma. The association was less strong for invasive cervical cancer with ORs ranging from 1.1 (0.7–1.2) to 1.6 (1.1–2.3), whereas ORs for squamous intraepithelial lesions were higher, from 4.4 (2.3–8.4) to 17.0 (2.2–134.1). For non AIDS-classifying cancers, squamous cell conjunctival carcinoma of the eye was associated with HIV in many case-referent studies with ORs from 2.6 (1.4–4.9) to 13.0 (4.5–39.4). A record-linkage study conducted in Uganda showed an association between Hodgkin lymphoma and HIV infection with a standardized incidence ratio of 5.7 (1.2–17) although OR in case-referent studies ranged from 1.4 (0.7–2.8) to 1.6 (1.0–2.7). Other cancer sites found positively associated with HIV include lung, liver, anus, penis, vulva, kidney, thyroid and uterus and a decreased risk of female breast cancer. These results so far based on a relatively small number of studies warrant further epidemiological investigations, taking into account other known risk factors for these tumors. Conclusion Studies conducted in sub-Saharan Africa show that HIV infection is not only strongly associated with AIDS-classifying cancers but also provided some evidence of association for other neoplasia. African countries need now to implement well designed population-based studies in order to better describe the spectrum of AIDS-associated malignancies and the most effective strategies for their prevention, screening and treatment.


Transfusion | 2011

Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008.

Yves Ozier; Jean-Yves Muller; Paul-Michel Mertes; Philippe Renaudier; Philippe Aguilon; N. Canivet; P. Fabrigli; Danielle Rebibo; Mahdi Tazerout; Catherine Trophilme; Béatrice Willaert; Cyril Caldani

BACKGROUND: Transfusion‐related acute lung injury (TRALI) is a major cause of transfusion‐related mortality and morbidity. Epidemiologic studies using data from national transfusion schemes can help achieve a better understanding of TRALI incidence.


Cancer Causes & Control | 2003

Smoking and non-Hodgkin's lymphoma: a case–control study in the Rhône-Alpes region of France

Hervé Besson; Philippe Renaudier; Ray M. Merrill; Bertrand Coiffier; Catherine Sebban; J. Fabry; Christian Trepo; Annie J. Sasco

Objective: To study the relation between smoking and non-Hodgkin/s lymphoma (NHL), in the Rhône-Alpes region of France. Methods: We conducted a hospital-based case–control study that included 180 cases of NHL and 360 age-, gender-matched hospital controls. Matched univariable and multivariable logistic regression models were used for analysis. Results: For the whole study population as well as for men, smoking does not elevate the risk of NHL. However, the risk of NHL is higher for women who currently smoke compared to women who have never smoked (odds ratio [OR] = 2.40, 95% confidence interval [95% CI] = 1.19–4.84). Among ever smokers, the OR of NHL is 5.04 (95% CI = 1.40–18.12) for women who have smoked for more than 30 years compared with those who have never smoked. Similarly, women who started to smoke before the age of 20 years compared with women who have never smoked are at greater risk of developing NHL (OR = 2.40, 95% CI = 0.99–5.85). In the total population (women and men), smoking may be associated with one histologic subtype, follicular NHL with an adjusted OR for the current smokers compared to subjects having never smoked of 3.20, 95% CI = 0.79–12.97. Conclusions: In spite of the small number of subjects in the subgroups, a relation is observed between smoking and NHL among women, but not men, and in the total population a relation is suggested between smoking and follicular NHL.


European Journal of Gastroenterology & Hepatology | 2004

Hepatitis C virus infection and B-cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France.

P. Sève; Philippe Renaudier; Annie J. Sasco; Charles Dumontet; Gilles Salles; Bertrand Coiffier; Fabien Zoulim; C. Broussolle; Christian Trepo

Objectives The role of hepatitis C virus (HCV) infection in the pathogenesis of non-Hodgkins lymphoma (NHL) is controversial. A high prevalence of HCV infection in patients with NHL has been reported in Italy and Japan. By contrast, several studies in Northern Europe and Canada have not found any increased prevalence of HCV in B-cell NHL, suggesting a possible geographic variation. We sought to determine whether such an association could be found in patients treated in the Rhône-Alpes region in south-east France. Our main interest was to identify histological subtypes preferentially linked to HCV. Methods We determined the prevalence of anti-HCV antibodies in 212 consecutive patients with B-cell NHL diagnosed in our institution between January 1997 and December 1998. The comparison group comprised 974 patients tested for HCV before transfusion at the same hospital during the same period. Results Anti-HCV antibodies were found in six (2.8%) NHL patients. The distribution by histopathological category was as follows: three gastric mucosa-associated lymphoid tissue (MALT) lymphomas, one marginal lymphoma and two diffuse large-cell lymphomas. Anti-HCV antibodies were found in 20 (2%) of 974 comparison patients. Overall, there was a positive but non-significant trend towards an association between NHL and HCV infection (odds ratio 1.31; 95% confidence interval 0.51–3.36). However, the prevalence of HCV antibodies was significantly higher in MALT lymphoma patients than in the comparison group (odds ratio 9.87; 95% confidence interval 2.59–37.69). Conclusions To our knowledge, this is the first French study to show an association between HCV and MALT lymphoma. These results, although derived from a small number of patients, suggest a possible role of HCV in gastric MALT lymphomagenesis.


Transfusion Clinique Et Biologique | 2010

Œdèmes pulmonaires transfusionnels : classification des cas notifiés en hémovigilance

Yves Ozier; Philippe Renaudier; Cyril Caldani; P. Aguilon; N. Canivet; P. Fabrigli; Paul-Michel Mertes; Jean-Yves Muller; Danielle Rebibo; M. Tazerout; C. Trophilme; Béatrice Willaert; M. Carlier

Pulmonary oedema after transfusion of blood products may be hydrostatic (transfusion-associated circulatory overload [taco]) or exsudative (transfusion-related acute lung injury [trali]). Both conditions have been recognized as major hazards to transfusion recipients. Risk characterization is necessary to improve safety and to monitor trends in the national blood transfusion system. A collaborative multidisciplinary working group of the French National Hemovigilance Committee has proposed an analysis framework for case definitions and classification. The method relies on internationally used definitions and is adapted to the codification procedures used in the french transfusion incident reports electronic data management.


Transfusion Clinique Et Biologique | 2016

OAP post-transfusionnel : rôle favorisant de l’hémosidérose ?

Anne Damais-Cepitelli; Isabelle Herve; Heidrun Andreu; Philippe Renaudier


Transfusion Clinique Et Biologique | 2016

Une expérience de recherche active des EIR : TACO

Dominique Maurière; Christophe Goetz; Sébastien Gette; Philippe Renaudier


Transfusion Clinique Et Biologique | 2010

Trali: analyse des cas notifis au rseau franais dhmovigilance en 20072008

Yves Ozier; Jean Yves Muller; Paul-Michel Mertes; Philippe Renaudier; P. Aguilon; N. Canivet; P. Fabrigli; Danielle Rebibo; M. Tazerout; C. Trophilme; Béatrice Willaert; Cyril Caldani


Transfusion Clinique Et Biologique | 2010

Trali : analyse des cas notifiés au réseau français d’hémovigilance en 2007–2008

Yves Ozier; Jean-Yves Muller; Paul-Michel Mertes; Philippe Renaudier; P. Aguilon; N. Canivet; P. Fabrigli; Danielle Rebibo; M. Tazerout; C. Trophilme; Béatrice Willaert; Cyril Caldani


Transfusion Clinique Et Biologique | 2008

Transfusion en hmatologie

Philippe Renaudier

Collaboration


Dive into the Philippe Renaudier's collaboration.

Top Co-Authors

Avatar

Béatrice Willaert

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Cyril Caldani

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Danielle Rebibo

Agence française de sécurité sanitaire des produits de santé

View shared research outputs
Top Co-Authors

Avatar

Yves Ozier

Paris Descartes University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Annie J. Sasco

French Institute of Health and Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hervé Besson

International Agency for Research on Cancer

View shared research outputs
Researchain Logo
Decentralizing Knowledge